Introduction: DM provokes peripheral complications and changes in central nervous system. Central changes in the course of diabetes mellitus (DM) include changes in brain tissue structure, electrophysiological abnormalities but also disturbances in neurotransmission leading to cognitive decline.
Introduction
Central changes in the course of diabetes mellitus (DM), both type 1 and 2, include changes in brain tissue structure, electrophysiological abnormalities but also disturbances in neurotransmission which were proved in experimental and clinical trials [1, 2, 3] . All those irregularities can lead to the loss of cognitive abilities, especially caused by DM complications and extreme high or low glucose levels [1, 4, 5] . There are only a few investigations concerning patients suffering from DM1 without distinct complications [6, 7] .
The aim of our study was to asses cognitive functioning of patients suffering from DM1 for at least 5 years but without diagnosed complications.
Materials and methods Patients
Including criteria were at least 5 years duration of DM1, intensive insulin-therapy treatment, no diagnosed complications of DM1. Excluding criteria were psychic disturbances, mental retardation, poor controlled hypertension, coronary heart disease, history of stroke or myocardial infarction, nephropathy, retinopathy, other acute diseases or significant deviations in laboratory tests. Experimental procedures have been approved by the Local Ethical Committee in Lublin. We examined 24 women and 35 men. Mean duration of DM 1 was 12.8 ±4.3 years. Mean age of patients was 32.5±7.4 years.
Experimental procedure Blood samples
Blood samples were taken between 8 and 9 a.m., after at least 8 hours fasting and night resting. Hypoglycemia occurring at the night before examination excluded patient from the study. After physical examination blood glucose level was checked once again. All psychological tests were performed after breakfast and insulin injection in comfortable conditions and desirable glucose level was maintained above 100 mg/dl. SCWT investigates executive functioning, attention deployment, cognitive flexibility and selective attention [5, 8] . TMT B investigates executive functions similarly to SCWT. Both TMT A and MT asses speed and motor control. RAVLT measuring memory, bases on memorizing string of words [5, 8] . BT is widely used to diagnose depression. MMSE is used to evaluate global cognitive function and to asseses stage of dementia [5] . Statistical analysis was performed using Statistica 8.0.
Cognitive function evaluation

Results
Mean results of laboratory tests are shown in table I. Women obtained better results in TMT B (p<0.01) and SCWT (p<0.01). Duration of disease influenced unfavorably the results of SCWT but only in the group of women (p<0.05). Together with increased number of episodes of moderate and severe hypoglycemia patients needed more time in MT (p<0.05). This dependence was especially significant in the group of women (p<0.01). Number of episodes of hypoglycemia in women but not in men also worsened results in TMT A and TMT B (both p<0.05).
There were no differences in performed tests between groups HbA1c <8 and >8 % but in group with higher level of HbA1c negative correlations with results in MT (p<0.01) and positive with RAVLT (p<0.05) were proved. Interestingly, we also found positive correlation of results in RAVLT and glucose level during examination (p<0.01) and this effect was present in the group of women but not men. On the other hand blood glucose level below 200 mg/dl may improve results only in SCWT (p=0.05). Disadvantageous influence on RAVLT results of total cholesterol (p<0.05), LDL cholesterol (p<0.01) and triglycerides (p>0.05) and advantageous influence of HDL cholesterol (p<0.05) were observed. Total cholesterol level above 200 mg/dl deteriorated results in TMT B (p<0.001) and SCWT (p<0.05). Elevated LDL cholesterol also worsen results in SCWT (p<0.05).
Discussion
Obtained results suggest that DM1 can affect different domains of cognitive functioning. Because better results of women in some tests, especially SCWT are described in literature, our results are especially distressing. It seems that particularly women are prone to hypoglycemia, which worsens executive functions, speed and motor control. Moreover in women worse glucose control disturbed cognitive functioning at the time of examination congruently with worse long time scores. Obtained results suggest that slight increase of total cholesterol, LDL cholesterol and triglyceride level disturb executive functions and reduced LDL level promotes speed and motor control and this relationship is not sex-dependent.
The relationship between sex and deterioration of frontal lobe function dependent on low glucose level is not unambiguous. Because no gender-related changes were reported, probably other than low glucose level, not defined factors can be significant. Our observation that time of duration of DM 1 can also lead to cognitive decline is confirmed in other investigations [7] . Poor glucose control and episodes of hypoglycemia also seem to be crucial. They are patient-dependent factors leading to cognitive decline [9] . Available data suggest that especially type of DM but also presence of nephropathy or retinopathy should be considered [4, 5] . However, in our group, no symptoms of angiopathy were diagnosed so other factors should be important. In different investiga-tions, cholesterol level was rather analyzed as a risk factor of atherogenesis but not the only factor leading to depletion of cognitive functions. It is known that treatment with statins does not improve results in neuropsychological tests despite of favorable effect on cholesterol fraction concentration and anti-inflammatory effect [10] . Moreover, many investigations concerned elderly or patients with DM2. Because DM1 is not only elevated glucose level but first of all a number of hormonal and metabolic abnormalities, the problem of cognitive decline seems to be intricate.
Conclusions
It seems that even apparent lack of complications is not unambiguous with no cognition decline and women can be more susceptible. DM1 affects children and young patients so explanation of reasons of those abnormalities is very important and needs further investigations.
